On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies

Abstract. There is growing interest in monitoring response to therapy in oncology patients using positron emission tomography and fluorine-18 fluorodeoxyglucose (FDG). Quantification is required, and various methods have been described. Arterial sampling, which provides the most accurate input function, often is not feasible in patients undergoing chemotherapy. In the thorax an image-derived input function can be obtained from the large vascular structures. In many studies the left ventricle (LV) is used, but the obtained data are rarely validated. In this study a simple quality control procedure for the image-derived input function was developed and compared with a standard LV curve. Twenty dynamic FDG scans were obtained in nine patients with non-small cell lung cancer stage IIIA-N2. Three venous blood samples were taken as a quality control for the image-derived input function. Regions of interest (ROIs) were defined for aorta, LV and left atrium. Input curves were generated according the the standard use of the LV curve and by applying the quality control method to all vascular ROIs. Tumour ROIs were defined and both input functions were used to calculate tumour glucose metabolism (MRglu), using both standard non-linear regression and Patlak analyses. Mean differences in MRglu using ”standard” LV and ”quality control approved” input functions were 16.2% and 17.5% for non-linear regression and Patlak analyses, respectively, iondicating that the use of ”standard” LV curve might lead to significant errors. It is concluded that care should be taken in using image derived input functions without appropriate quality control. The proposed procedure is simple and results in significantly more accurate MRglu data.

[1]  M E Phelps,et al.  Derivation of input function from FDG-PET studies in small hearts. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  G Brix,et al.  Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  K. Erlandsson,et al.  An alternative method to normalize clinical FDG studies. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  M. Phelps,et al.  Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  M E Phelps,et al.  Correction of spillover radioactivities for estimation of the blood time-activity curve from the imaged LV chamber in cardiac dynamic FDG PET studies. , 1995, Physics in medicine and biology.

[6]  T D Cradduck,et al.  National electrical manufacturers association , 1983, Journal of the A.I.E.E..

[7]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  R L Wahl,et al.  Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P Suetens,et al.  Three-dimensional correction for spillover and recovery of myocardial PET images. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  D. Feng,et al.  Noninvasive Quantification of the Cerebral Metabolic Rate for Glucose Using Positron Emission Tomography, 18F-Fluoro-2-Deoxyglucose, the Patlak Method, and an Image-Derived Input Function , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  A. Fischman,et al.  Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  Michael E. Phelps,et al.  Quantitation in Positron Emission Computed Tomography , 1980 .

[13]  R. Hustinx,et al.  Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. , 1997, The European respiratory journal.

[14]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[15]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.

[16]  R L Wahl,et al.  Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  M Schwaiger,et al.  Breast imaging with fluorine-18-FDG PET: quantitative image analysis. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  Scott T. Grafton,et al.  PET and [18F]-FDG in oncology: a clinical update. , 1996, Nuclear medicine and biology.